The ADDUCE Consortium
The ADDUCE Project
What is ADHD?
Patients and relatives
University College Cork
Brief description of the organization
University College Cork has one of Ireland’s most successful and active research programmes. UCC has research income which is consistently one of the highest in the country and it has an outstanding international reputation in research across all faculties. The School of Pharmacy provides world class standards in teaching and research and is recognized for excellence in both areas in Ireland.
UCC has a strong research ethics governance structure promoting an ethical approach to research across UCC. The Academic Council Research Committee comprises three sub‐committees of which one is the Clinical Research Ethics Committee of the Cork Teaching Hospitals (CREC) dealing with clinical research involving human participants, their identifiable data or tissue. This Committee is recognized by the Department of Health and Children as a nationally competent ethics committee for clinical trials under the European Communities and provides a wealth of experience on ethical issues of clinical trials. Suzanne McCarthy was an expert member of the Great Ormond Street/Institute of Child Health (GOSH/ICH) research ethics committee for a number of years and has dealt extensively with ethical issues in paediatric clinical research. UCC has also been involved previously in ethical aspects of European projects. Suzanne McCarthy has conducted a number of pharmacoepidemiological studies examining the prescribing trends of methylphenidate, dexamphetamine and atomoxetine in primary care using the General Practice Research Database (McCarthy et al 2009a). In addition, Suzanne McCarthy has conducted a pharmacovigilance study looking at the issue of mortality and ADHD drugs, using the GPRD (McCarthy et al 2009b).
Profile of staff members
Suzanne McCarthy (MPharm PhD) is a lecturer in clinical pharmacy at the School of Pharmacy, University College Cork. She has experience in conducting pharmacoepidemiological studies using large automated databases, specifically examining prescribing trends and safety of ADHD drugs. She also has experience of reviewing research ethics proposals of trials involving children through her time as an expert member of the GOSH/ICH research ethics committee.
Main tasks in the project
The University of Cork is responsible for WP9 (Ethics). In addition it will contribute to the retrospective data acquisition in WP2.
The fifth ADDUCE Newsletter is now available!
Here, you can read about the finalisation of the project,
the European Medicines Agency and General Assembly meetings
and the dissemination of the results!
The fourth ADDUCE Newsletter is available!
In this newsletter, you can find some information on the final recruitment status of the 2 main studies:
- the prospective open-label methylphenidate pharmacovigilance study
- the long-term cardiascular effects of methylphenidate use
Also, you can read about the future plans of the project!
More than 1500 children, adolescents and adults across all Europe already took part in our study! Thanks to them, we have already gathered lots of information so we can know a lot more about methylphenidate than ever before!
Did you participate in the ADDUCE studies and are you curious about the latest news on the project?
Here you can find some information!
News for children, April 2015
News for adolescents, April 2015
News for parents, April 2015
The third ADDUCE Newsletter is available!
Read more about the ADDUCE studies:
- the prospective open-label methylphenidate pharmacovigilance study: recruitment status and spin-
- the long-term cardiovascular effects of methylphenidate use: study design and participation
and much more in the ADDUCE Newsletter 3, March 2015
The second ADDUCE Newsletter is available!
Read more about the 2 main ADDUCE studies:
WP3: prospective open-label methylphenidate
- WP8: long-term cardiovascular effects of methylphenidate use
and much more in the ADDUCE Newsletter 2, February 2013
16 - 19 OCTOBER 2016:
4rd EUNETHYDIS International Conference on ADHD, Berlin - Germany
from basis neuroscience to optimised clinical care
17 & 18 APRIL 2016:
ADDUCE Consortium meeting, London - UK
28 - 31 MAY 2015:
5th World Congress on ADHD: from Child to Adult Disorder, Glasgow - Scotland
20 & 21 APRIL 2015:
ADDUCE Consortium meeting, Salina - Italy
21 - 24 MAY 2014:
3rd EUNETHYDIS International Conference on ADHD, Istanbul - Turkey
ADHD and related disorders
19 & 20 MAY 2014:
ADDUCE Consortium meeting, Istanbul - Turkey
3 - 6 OCTOBER 2013:
23rd EUNETHYDIS Network Meeting, Prague Czech Republic
A meeting of the European Network of Hyperkinetic Disorders
6 - 9 JUNE 2013:
4th World Congress on ADHD: from Childhood to Adult Disease, Milan - Italy
4 & 5 JUNE 2013:
ADDUCE Consortium meeting, Milan - Italy
6 & 7 JUNE 2012:
ADDUCE Consortium meeting, Cagliari - Italy
23 MAY 2012:
2nd EUNETHYDIS International Conference on ADHD, Barcelona - Spain